161 related articles for article (PubMed ID: 35214089)
21. Temperature Dependence of the Complexation Mechanism of Celecoxib and Hydroxyl-β-cyclodextrin in Aqueous Solution.
Chiang PC; Shi Y; Cui Y
Pharmaceutics; 2014 Aug; 6(3):467-80. PubMed ID: 25123365
[TBL] [Abstract][Full Text] [Related]
22. Formulation and Evaluation of Supramolecular Food-Grade Piperine HP β CD and TPGS Complex: Dissolution, Physicochemical Characterization, Molecular Docking, In Vitro Antioxidant Activity, and Antimicrobial Assessment.
Imam SS; Alshehri S; Alzahrani TA; Hussain A; Altamimi MA
Molecules; 2020 Oct; 25(20):. PubMed ID: 33066657
[TBL] [Abstract][Full Text] [Related]
23. 2-hydroxypropyl-beta-cyclodextrin increases aqueous solubility and photostability of all-trans-retinoic acid.
Lin HS; Chean CS; Ng YY; Chan SY; Ho PC
J Clin Pharm Ther; 2000 Aug; 25(4):265-9. PubMed ID: 10971776
[TBL] [Abstract][Full Text] [Related]
24. Preparation, characterization and in vivo evaluation of formulation of repaglinide with hydroxypropyl-β-cyclodextrin.
Liu M; Cao W; Sun Y; He Z
Int J Pharm; 2014 Dec; 477(1-2):159-66. PubMed ID: 25455768
[TBL] [Abstract][Full Text] [Related]
25. Inclusion complexes of chlorzoxazone with β- and hydroxypropyl-β-cyclodextrin: Characterization, dissolution, and cytotoxicity.
Tang P; Li S; Wang L; Yang H; Yan J; Li H
Carbohydr Polym; 2015 Oct; 131():297-305. PubMed ID: 26256188
[TBL] [Abstract][Full Text] [Related]
26. Super Aqueous Solubility of Albendazole in β-Cyclodextrin for Parenteral Application in Cancer therapy.
Pillai K; Akhter J; Morris DL
J Cancer; 2017; 8(6):913-923. PubMed ID: 28529602
[TBL] [Abstract][Full Text] [Related]
27. Comparison of cefpodoxime proxetil release and antimicrobial activity from tablet formulations: complexation with hydroxypropyl-β-cyclodextrin in the presence of water soluble polymer.
Gundogdu E; Koksal C; Karasulu E
Drug Dev Ind Pharm; 2012 Jun; 38(6):689-96. PubMed ID: 22010782
[TBL] [Abstract][Full Text] [Related]
28. Improvement of solubility and oral bioavailability of rutin by complexation with 2-hydroxypropyl-beta-cyclodextrin.
Miyake K; Arima H; Hirayama F; Yamamoto M; Horikawa T; Sumiyoshi H; Noda S; Uekama K
Pharm Dev Technol; 2000; 5(3):399-407. PubMed ID: 10934740
[TBL] [Abstract][Full Text] [Related]
29. Inclusion complex of barbigerone with hydroxypropyl-β-cyclodextrin: preparation and in vitro evaluation.
Qiu N; Cheng X; Wang G; Wang W; Wen J; Zhang Y; Song H; Ma L; Wei Y; Peng A; Chen L
Carbohydr Polym; 2014 Jan; 101():623-30. PubMed ID: 24299819
[TBL] [Abstract][Full Text] [Related]
30. Characterization of cyclodextrin inclusion complexes of the anti-HIV non-nucleoside reverse transcriptase inhibitor UC781.
Yang H; Parniak MA; Isaacs CE; Hillier SL; Rohan LC
AAPS J; 2008 Dec; 10(4):606-13. PubMed ID: 19089644
[TBL] [Abstract][Full Text] [Related]
31. Photosensitization of a subcutaneous tumour by the natural anthraquinone parietin and blue light.
Mugas ML; Calvo G; Marioni J; Céspedes M; Martinez F; Vanzulli S; Sáenz D; Di Venosa G; Nuñez Montoya S; Casas A
Sci Rep; 2021 Dec; 11(1):23820. PubMed ID: 34893702
[TBL] [Abstract][Full Text] [Related]
32. An investigation into the supramolecular structure, solubility, stability and antioxidant activity of rutin/cyclodextrin inclusion complex.
Nguyen TA; Liu B; Zhao J; Thomas DS; Hook JM
Food Chem; 2013 Jan; 136(1):186-92. PubMed ID: 23017411
[TBL] [Abstract][Full Text] [Related]
33. Enhanced cellular uptake and osteogenic differentiation efficiency of melatonin by inclusion complexation with 2-hydroxypropyl β-cyclodextrin.
Terauchi M; Tamura A; Yamaguchi S; Yui N
Int J Pharm; 2018 Aug; 547(1-2):53-60. PubMed ID: 29803791
[TBL] [Abstract][Full Text] [Related]
34. Electrospun formulation of acyclovir/cyclodextrin nanofibers for fast-dissolving antiviral drug delivery.
Celebioglu A; Uyar T
Mater Sci Eng C Mater Biol Appl; 2021 Jan; 118():111514. PubMed ID: 33255070
[TBL] [Abstract][Full Text] [Related]
35. Complexation of zolpidem with 2-hydroxypropyl-beta-, methyl-beta-, and 2-hydroxypropyl-gamma-cyclodextrin: effect on aqueous solubility, dissolution rate, and ataxic activity in rat.
Trapani G; Latrofa A; Franco M; Pantaleo MR; Sanna E; Massa F; Tuveri F; Liso G
J Pharm Sci; 2000 Nov; 89(11):1443-51. PubMed ID: 11015689
[TBL] [Abstract][Full Text] [Related]
36. A promising antitumor activity of evodiamine incorporated in hydroxypropyl-β-cyclodextrin: pro-apoptotic activity in human hepatoma HepG2 cells.
Qiu C; Gao LN; Yan K; Cui YL; Zhang Y
Chem Cent J; 2016; 10():46. PubMed ID: 27458481
[TBL] [Abstract][Full Text] [Related]
37. Preparation and characterization of hydroxypropyl-β-cyclodextrin inclusion complex of eugenol: differential pulse voltammetry and (1)H-NMR.
Garg A; Gupta B; Prakash R; Singh S
Chem Pharm Bull (Tokyo); 2010 Oct; 58(10):1313-9. PubMed ID: 20930396
[TBL] [Abstract][Full Text] [Related]
38. Formulation and development of extended-release micro particulate drug delivery system of solubilized rifaximin.
Karanje RV; Bhavsar YV; Jahagirdar KH; Bhise KS
AAPS PharmSciTech; 2013 Jun; 14(2):639-48. PubMed ID: 23516110
[TBL] [Abstract][Full Text] [Related]
39. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
[TBL] [Abstract][Full Text] [Related]
40. Photoactive Parietin-loaded nanocarriers as an efficient therapeutic platform against triple-negative breast cancer.
Ayoub AM; Atya MS; Abdelsalam AM; Schulze J; Amin MU; Engelhardt K; Wojcik M; Librizzi D; Yousefi BH; Nasrullah U; Pfeilschifter J; Bakowsky U; Preis E
Int J Pharm; 2023 Aug; 643():123217. PubMed ID: 37429562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
